James McArthur, CEO of PepGen, discusses his venture capital experience and how it influences his management style. He explores drug development in rare diseases, particularly neuromuscular diseases. He highlights the importance of multiple treatment options and patient organizations. He also talks about adapting to a changing environment during the pandemic and the value of surrounding oneself with good people.